NASDAQ:BDTX | Insider Transactions | Black Diamond Therapeutics, Inc.

BDTX Insider Transactions

467 retained open-market purchase and sale rows from SEC Forms 3, 4 and 5, newest first. This page shows rows 1–100; provenance stays internal.

BDTX insiders transaction timeline

PurchaseSale
2020-02-03: 29 purchases — Behbahani Ali, Versant Venture Capital VI, L.P., Versant Voyageurs I, L.P. and 9 more2020-08-10: 10 sales — Versant Venture Capital VI, L.P., Versant Voyageurs I, L.P., Versant Voyageurs I Parallel, L.P. and 2 more2020-08-11: 10 sales — Versant Venture Capital VI, L.P., Versant Voyageurs I, L.P., Versant Voyageurs I Parallel, L.P. and 2 more2020-09-03: 2 sales — Roberts Christopher D.2020-09-14: 4 sales — Hatzis-Schoch Brent, Leggett Thomas2020-09-30: 1 purchase — INGRAM ROBERT ALEXANDER2020-10-01: 1 sale — Epstein David M.2020-10-05: 2 sales — Roberts Christopher D.2020-10-06: 10 sales — Bolzon Bradley J PhD, Versant Venture Capital VI, L.P., Versant Voyageurs I, L.P. and 2 more2020-10-07: 10 sales — Bolzon Bradley J PhD, Versant Venture Capital VI, L.P., Versant Voyageurs I, L.P. and 2 more2020-10-08: 21 sales — Bolzon Bradley J PhD, Versant Venture Capital VI, L.P., Versant Voyageurs I, L.P. and 3 more2020-10-09: 10 sales — Bolzon Bradley J PhD, Versant Venture Capital VI, L.P., Versant Voyageurs I, L.P. and 2 more2020-10-12: 12 sales — Hatzis-Schoch Brent, Bolzon Bradley J PhD, Versant Venture Capital VI, L.P. and 3 more2020-10-13: 10 sales — Bolzon Bradley J PhD, Versant Venture Capital VI, L.P., Versant Voyageurs I, L.P. and 2 more2020-10-14: 10 sales — Bolzon Bradley J PhD, Versant Venture Capital VI, L.P., Versant Voyageurs I, L.P. and 2 more2020-10-15: 10 sales — Versant Venture Capital VI, L.P., Versant Voyageurs I, L.P., Versant Voyageurs I Parallel, L.P. and 2 more2020-10-16: 10 sales — Versant Venture Capital VI, L.P., Versant Voyageurs I, L.P., Versant Voyageurs I Parallel, L.P. and 2 more2020-10-19: 10 sales — Versant Venture Capital VI, L.P., Versant Voyageurs I, L.P., Versant Voyageurs I Parallel, L.P. and 2 more2020-10-26: 10 sales — Versant Venture Capital VI, L.P., Versant Voyageurs I, L.P., Versant Voyageurs I Parallel, L.P. and 2 more2020-10-27: 10 sales — Versant Venture Capital VI, L.P., Versant Voyageurs I, L.P., Versant Voyageurs I Parallel, L.P. and 2 more2020-11-02: 2 sales — Epstein David M.2020-11-03: 1 sale — Roberts Christopher D.2020-11-04: 10 sales — Bolzon Bradley J PhD, Versant Venture Capital VI, L.P., Versant Voyageurs I, L.P. and 2 more2020-11-05: 10 sales — Bolzon Bradley J PhD, Versant Venture Capital VI, L.P., Versant Voyageurs I, L.P. and 2 more2020-11-06: 10 sales — Versant Venture Capital VI, L.P., Versant Voyageurs I, L.P., Versant Voyageurs I Parallel, L.P. and 2 more2020-11-09: 11 sales — Leggett Thomas, Versant Venture Capital VI, L.P., Versant Voyageurs I, L.P. and 3 more2020-11-10: 20 sales — Versant Venture Capital VI, L.P., Versant Voyageurs I, L.P., Versant Voyageurs I Parallel, L.P. and 2 more2020-11-11: 21 sales — Roberts Christopher D., Versant Venture Capital VI, L.P., Versant Voyageurs I, L.P. and 3 more2020-11-12: 33 sales — Versant Venture Capital VI, L.P., Versant Voyageurs I, L.P., Versant Voyageurs I Parallel, L.P. and 3 more2020-11-13: 20 sales — Versant Venture Capital VI, L.P., Versant Voyageurs I, L.P., Versant Voyageurs I Parallel, L.P. and 2 more2020-11-16: 10 sales — Versant Venture Capital VI, L.P., Versant Voyageurs I, L.P., Versant Voyageurs I Parallel, L.P. and 2 more2020-11-17: 10 sales — Bolzon Bradley J PhD, Versant Venture Capital VI, L.P., Versant Voyageurs I, L.P. and 2 more2020-11-18: 10 sales — Bolzon Bradley J PhD, Versant Venture Capital VI, L.P., Versant Voyageurs I, L.P. and 2 more2020-11-19: 10 sales — Versant Venture Capital VI, L.P., Versant Voyageurs I, L.P., Versant Voyageurs I Parallel, L.P. and 2 more2020-11-30: 10 sales — Bolzon Bradley J PhD, Versant Venture Capital VI, L.P., Versant Voyageurs I, L.P. and 2 more2020-12-01: 2 sales — Epstein David M.2020-12-03: 1 sale — Roberts Christopher D.2020-12-08: 2 sales — Leggett Thomas2020-12-14: 1 sale — Hatzis-Schoch Brent2021-01-04: 4 sales — Roberts Christopher D., Epstein David M.2021-01-08: 1 sale — Leggett Thomas2021-01-12: 6 sales — Hatzis-Schoch Brent2021-02-03: 1 sale — Roberts Christopher D.2021-02-12: 2 sales — Hatzis-Schoch Brent2021-03-03: 2 sales — Roberts Christopher D.2021-03-12: 1 sale — Hatzis-Schoch Brent2021-04-05: 1 sale — Roberts Christopher D.2021-04-12: 1 sale — Hatzis-Schoch Brent2021-05-03: 1 sale — Roberts Christopher D.2021-05-12: 3 sales — Hatzis-Schoch Brent2022-04-12: 2 purchases — BB BIOTECH AG, BIOTECH GROWTH N V2022-04-13: 2 purchases — BB BIOTECH AG, BIOTECH GROWTH N V2022-04-18: 2 purchases — BB BIOTECH AG, BIOTECH GROWTH N V2022-04-19: 2 purchases — BB BIOTECH AG, BIOTECH GROWTH N V2022-04-27: 2 purchases — BB BIOTECH AG, BIOTECH GROWTH N V2022-04-28: 2 purchases — BB BIOTECH AG, BIOTECH GROWTH N V2022-06-29: 1 purchase — Ni Fang2022-10-19: 2 purchases — BB BIOTECH AG, BIOTECH GROWTH N V2022-10-20: 2 purchases — BB BIOTECH AG, BIOTECH GROWTH N V2022-10-21: 2 purchases — BB BIOTECH AG, BIOTECH GROWTH N V2022-10-27: 2 purchases — BB BIOTECH AG, BIOTECH GROWTH N V2022-10-28: 2 purchases — BB BIOTECH AG, BIOTECH GROWTH N V2022-10-31: 2 purchases — BB BIOTECH AG, BIOTECH GROWTH N V2022-12-21: 1 purchase — Ni Fang2022-12-22: 1 purchase — Ni Fang2023-06-27: 2 purchases — BB BIOTECH AG, BIOTECH GROWTH N V2023-06-27: 1 sale — Epstein David M.2023-06-30: 2 purchases — BB BIOTECH AG, BIOTECH GROWTH N V2023-07-05: 6 purchases — RA Capital Healthcare Fund LP, RA CAPITAL MANAGEMENT, L.P., Kolchinsky Peter and 3 more2023-10-17: 2 purchases — BB BIOTECH AG, BIOTECH GROWTH N V2024-08-28: 4 sales — Versant Venture Capital VI, L.P., Versant Voyageurs I, L.P., Versant Voyageurs I Parallel, L.P. and 1 more2025-03-19: 14 sales — BB BIOTECH AG, BIOTECH GROWTH N V2020-02-032025-03-19
Insider profileRoleDateTransactionSharesPrice
BB BIOTECH AGTenPercentOwner2025-03-19Sale500,000.0$2.12
BIOTECH GROWTH N VTenPercentOwner2025-03-19Sale500,000.0$2.12
BB BIOTECH AGTenPercentOwner2025-03-19Sale584,292.0$1.95
BIOTECH GROWTH N VTenPercentOwner2025-03-19Sale584,292.0$1.95
BB BIOTECH AGTenPercentOwner2025-03-19Sale400,000.0$2.09
BIOTECH GROWTH N VTenPercentOwner2025-03-19Sale400,000.0$2.09
BB BIOTECH AGTenPercentOwner2025-03-19Sale2,000,000.0$2.0
BIOTECH GROWTH N VTenPercentOwner2025-03-19Sale2,000,000.0$2.0
BB BIOTECH AGTenPercentOwner2025-03-19Sale1,000,000.0$2.31
BIOTECH GROWTH N VTenPercentOwner2025-03-19Sale1,000,000.0$2.31
BB BIOTECH AGTenPercentOwner2025-03-19Sale300,000.0$1.94
BIOTECH GROWTH N VTenPercentOwner2025-03-19Sale300,000.0$1.94
BB BIOTECH AGTenPercentOwner2025-03-19Sale1,000,000.0$2.07
BIOTECH GROWTH N VTenPercentOwner2025-03-19Sale1,000,000.0$2.07
Versant Venture Capital VI, L.P.TenPercentOwner2024-08-28Sale221,600.0$6.32
Versant Voyageurs I, L.P.TenPercentOwner2024-08-28Sale221,600.0$6.32
Versant Voyageurs I Parallel, L.P.TenPercentOwner2024-08-28Sale221,600.0$6.32
Versant Vantage I, L.P.TenPercentOwner2024-08-28Sale221,600.0$6.32
BB BIOTECH AGTenPercentOwner2023-10-17Purchase400,000.0$2.34
BIOTECH GROWTH N VTenPercentOwner2023-10-17Purchase400,000.0$2.34
RA Capital Healthcare Fund LPDirector2023-07-05Purchase935,850.0$5.0
RA CAPITAL MANAGEMENT, L.P.Director2023-07-05Purchase935,850.0$5.0
Kolchinsky PeterDirector2023-07-05Purchase935,850.0$5.0
Shah Rajeev M.Director2023-07-05Purchase935,850.0$5.0
RA Capital Nexus Fund, L.P.Director2023-07-05Purchase935,850.0$5.0
Behbahani AliDirector2023-07-05Purchase1,000,000.0$5.0
BB BIOTECH AGTenPercentOwner2023-06-30Purchase1,000,000.0$5.0
BIOTECH GROWTH N VTenPercentOwner2023-06-30Purchase1,000,000.0$5.0
BB BIOTECH AGTenPercentOwner2023-06-27Purchase1,740,000.0$5.49
BIOTECH GROWTH N VTenPercentOwner2023-06-27Purchase1,740,000.0$5.49
Epstein David M.SEE REMARKS2023-06-27Sale25,000.0$6.7
Ni FangSEE REMARKS2022-12-22Purchase36,363.0$1.28
Ni FangSEE REMARKS2022-12-21Purchase20,000.0$1.29
BB BIOTECH AGTenPercentOwner2022-10-31Purchase99,801.0$2.25
BIOTECH GROWTH N VTenPercentOwner2022-10-31Purchase99,801.0$2.25
BB BIOTECH AGTenPercentOwner2022-10-28Purchase172,974.0$2.18
BIOTECH GROWTH N VTenPercentOwner2022-10-28Purchase172,974.0$2.18
BB BIOTECH AGTenPercentOwner2022-10-27Purchase191,678.0$1.87
BIOTECH GROWTH N VTenPercentOwner2022-10-27Purchase191,678.0$1.87
BB BIOTECH AGTenPercentOwner2022-10-21Purchase87,850.0$1.51
BIOTECH GROWTH N VTenPercentOwner2022-10-21Purchase87,850.0$1.51
BB BIOTECH AGTenPercentOwner2022-10-20Purchase53,734.0$1.42
BIOTECH GROWTH N VTenPercentOwner2022-10-20Purchase53,734.0$1.42
BB BIOTECH AGTenPercentOwner2022-10-19Purchase77,689.0$1.32
BIOTECH GROWTH N VTenPercentOwner2022-10-19Purchase77,689.0$1.32
Ni FangSEE REMARKS2022-06-29Purchase25,000.0$2.44
BB BIOTECH AGTenPercentOwner2022-04-28Purchase255,711.0$2.57
BIOTECH GROWTH N VTenPercentOwner2022-04-28Purchase255,711.0$2.57
BB BIOTECH AGTenPercentOwner2022-04-27Purchase150,000.0$2.66
BIOTECH GROWTH N VTenPercentOwner2022-04-27Purchase150,000.0$2.66
BB BIOTECH AGTenPercentOwner2022-04-19Purchase150,000.0$3.24
BIOTECH GROWTH N VTenPercentOwner2022-04-19Purchase150,000.0$3.24
BB BIOTECH AGTenPercentOwner2022-04-18Purchase150,000.0$3.29
BIOTECH GROWTH N VTenPercentOwner2022-04-18Purchase150,000.0$3.29
BB BIOTECH AGTenPercentOwner2022-04-13Purchase102,556.0$3.57
BIOTECH GROWTH N VTenPercentOwner2022-04-13Purchase102,556.0$3.57
BB BIOTECH AGTenPercentOwner2022-04-12Purchase150,000.0$3.42
BIOTECH GROWTH N VTenPercentOwner2022-04-12Purchase150,000.0$3.42
Hatzis-Schoch BrentSee Remarks2021-05-12Sale351.0$28.2
Hatzis-Schoch BrentSee Remarks2021-05-12Sale2,566.0$27.9
Hatzis-Schoch BrentSee Remarks2021-05-12Sale1,161.0$26.11
Roberts Christopher D.Chief Scientific Officer2021-05-03Sale2,500.0$26.64
Hatzis-Schoch BrentSee Remarks2021-04-12Sale4,078.0$25.0
Roberts Christopher D.Chief Scientific Officer2021-04-05Sale2,500.0$25.54
Hatzis-Schoch BrentSee Remarks2021-03-12Sale4,078.0$26.36
Roberts Christopher D.Chief Scientific Officer2021-03-03Sale884.0$26.57
Roberts Christopher D.Chief Scientific Officer2021-03-03Sale1,616.0$25.85
Hatzis-Schoch BrentSee Remarks2021-02-12Sale307.0$27.66
Hatzis-Schoch BrentSee Remarks2021-02-12Sale3,771.0$27.19
Roberts Christopher D.Chief Scientific Officer2021-02-03Sale2,500.0$25.35
Hatzis-Schoch BrentSee Remarks2021-01-12Sale7,511.0$36.0
Hatzis-Schoch BrentSee Remarks2021-01-12Sale100.0$34.13
Hatzis-Schoch BrentSee Remarks2021-01-12Sale103.0$32.5
Hatzis-Schoch BrentSee Remarks2021-01-12Sale147.0$31.91
Hatzis-Schoch BrentSee Remarks2021-01-12Sale1,669.0$30.5
Hatzis-Schoch BrentSee Remarks2021-01-12Sale2,048.0$29.92
Leggett ThomasChief Financial Officer2021-01-08Sale3,000.0$33.94
Roberts Christopher D.Chief Scientific Officer2021-01-04Sale537.0$31.78
Roberts Christopher D.Chief Scientific Officer2021-01-04Sale1,963.0$31.31
Epstein David M.See Remarks2021-01-04Sale2,015.0$31.8
Epstein David M.See Remarks2021-01-04Sale9,985.0$30.99
Hatzis-Schoch BrentSee Remarks2020-12-14Sale4,078.0$34.95
Leggett ThomasChief Financial Officer2020-12-08Sale1,941.0$34.05
Leggett ThomasChief Financial Officer2020-12-08Sale1,059.0$33.27
Roberts Christopher D.Chief Scientific Officer2020-12-03Sale2,500.0$32.42
Epstein David M.See Remarks2020-12-01Sale1,077.0$33.45
Epstein David M.See Remarks2020-12-01Sale10,923.0$32.64
Bolzon Bradley J PhDDirector,TenPercentOwner2020-11-30Sale200.0$34.16
Bolzon Bradley J PhDDirector,TenPercentOwner2020-11-30Sale10,193.0$33.13
Versant Venture Capital VI, L.P.TenPercentOwner2020-11-30Sale200.0$34.16
Versant Voyageurs I, L.P.TenPercentOwner2020-11-30Sale200.0$34.16
Versant Voyageurs I Parallel, L.P.TenPercentOwner2020-11-30Sale200.0$34.16
Versant Vantage I, L.P.TenPercentOwner2020-11-30Sale200.0$34.16
Versant Venture Capital VI, L.P.TenPercentOwner2020-11-30Sale10,193.0$33.13
Versant Voyageurs I, L.P.TenPercentOwner2020-11-30Sale10,193.0$33.13
Versant Voyageurs I Parallel, L.P.TenPercentOwner2020-11-30Sale10,193.0$33.13
Versant Vantage I, L.P.TenPercentOwner2020-11-30Sale10,193.0$33.13
Versant Venture Capital VI, L.P.TenPercentOwner2020-11-19Sale114,854.0$33.01
Versant Voyageurs I, L.P.TenPercentOwner2020-11-19Sale114,854.0$33.01
Versant Voyageurs I Parallel, L.P.TenPercentOwner2020-11-19Sale114,854.0$33.01